Citadel Advisors - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$5,178,295
-3.9%
202,673
+7.9%
0.00%0.0%
Q2 2023$5,386,420
-39.5%
187,811
-49.4%
0.00%
-50.0%
Q1 2023$8,902,194
+16.0%
371,389
-17.9%
0.00%0.0%
Q4 2022$7,676,198
+76.5%
452,606
+54.2%
0.00%
+100.0%
Q3 2022$4,350,000
+62.8%
293,503
+72.9%
0.00%
Q2 2022$2,672,000
-54.8%
169,736
-22.6%
0.00%
-100.0%
Q1 2022$5,911,000
+23.6%
219,233
+69.7%
0.00%
+100.0%
Q4 2021$4,782,000
-41.8%
129,217
-24.8%
0.00%
-50.0%
Q3 2021$8,216,000
+442.0%
171,937
+283.8%
0.00%
Q2 2021$1,516,000
-89.0%
44,800
-86.5%
0.00%
-100.0%
Q1 2021$13,728,000
+14.5%
332,421
+20.2%
0.00%
+33.3%
Q4 2020$11,992,000
-29.7%
276,450
-30.4%
0.00%
-50.0%
Q3 2020$17,050,000
-53.7%
397,449
-49.6%
0.01%
-57.1%
Q2 2020$36,850,000
+8736.9%
788,384
+2464.9%
0.01%
Q1 2020$417,000
+195.7%
30,738
+137.7%
0.00%
Q4 2019$141,00012,9330.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders